30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Non-Expert Quiz Show Podcast

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode takes the format of an educational quiz show that explores pharmaceutical drug development, with a focus on FDA guidelines and safety protocols. The hosts discuss important topics including nitrosamines and mutagenic impurities in medications, the four phases of clinical trials, and the role of psychedelics in treating mental health conditions and end-of-life care. The episode concludes with a discussion about the future of pharmaceuticals, including AI drug development and personalized medicine.

NOW PLAYING

0:00 14:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 14 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 31, 2025.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!